ObjectivesThe distinction between bipolar I disorder (BD-I) and bipolar II disorder (BD-II) has been a topic of long-lasting debate. This study examined differences between BD-I and BD-II in a large, global sample of OABD, focusing on general functioning, cognition and somatic burden as these domains are often affected in OABD.MethodsCross-sectional analyses were conducted with data from the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) database. The sample included 963 participants aged ≥50 years (714 BD-I, 249 BD-II). Sociodemographic and clinical factors were compared between BD subtypes including adjustment for study cohort. Multivariable analyses were conducted with generalized linear mixed models (GLMMs) and est...
Objectives: Antipsychotic drugs (APS) are widely used to treat patients with bipolar disorder (BD), ...
Bipolar disorder type II (BDII) has been considered since its distinction from bipolar disorder type...
Objectives: In the coming generation, older adults with bipolar disorder (BD) will increase in absol...
Differences between BD-I and BD-II patients with regard to specific illness characteristics are poor...
OBJECTIVE: Literature on older-age bipolar disorder (OABD) is limited. This first-ever analysis of t...
Objective: There is a dearth of research about the aging process among individuals with bipolar diso...
Bipolar disorders (BDs) are prevalent, comorbid and disabling conditions, associated with the highes...
Objective: Some individuals with bipolar disorder (BD) experience manic and depressive symptoms conc...
Objectives: Late-onset bipolar disorder (LOBD) represents a significant subgroup of bipolar disorder...
OBJECTIVE: Some individuals with bipolar disorder (BD) experience manic and depressive symptoms conc...
Objective: The purpose of this study was to analyze differences in clinical and socio-demographic ch...
Bipolar disorder (BD) is a heritable psychiatric illness typically characterized by cyclic mood epis...
Objectives: Antipsychotic drugs (APS) are widely used to treat patients with bipolar disorder (BD), ...
Bipolar disorder type II (BDII) has been considered since its distinction from bipolar disorder type...
Objectives: In the coming generation, older adults with bipolar disorder (BD) will increase in absol...
Differences between BD-I and BD-II patients with regard to specific illness characteristics are poor...
OBJECTIVE: Literature on older-age bipolar disorder (OABD) is limited. This first-ever analysis of t...
Objective: There is a dearth of research about the aging process among individuals with bipolar diso...
Bipolar disorders (BDs) are prevalent, comorbid and disabling conditions, associated with the highes...
Objective: Some individuals with bipolar disorder (BD) experience manic and depressive symptoms conc...
Objectives: Late-onset bipolar disorder (LOBD) represents a significant subgroup of bipolar disorder...
OBJECTIVE: Some individuals with bipolar disorder (BD) experience manic and depressive symptoms conc...
Objective: The purpose of this study was to analyze differences in clinical and socio-demographic ch...
Bipolar disorder (BD) is a heritable psychiatric illness typically characterized by cyclic mood epis...
Objectives: Antipsychotic drugs (APS) are widely used to treat patients with bipolar disorder (BD), ...
Bipolar disorder type II (BDII) has been considered since its distinction from bipolar disorder type...
Objectives: In the coming generation, older adults with bipolar disorder (BD) will increase in absol...